Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 cell counts have higher mortality than the general population is unknown. We aimed to examine this by analysis of pooled data from industrialised countries
Using data from a large European collaborative study, we aimed to identify the circumstances in whic...
Background: Due to the success of antiretroviral therapy (ART), it is relevant to ask whether death ...
Using data from a large European collaborative study, we aimed to identify the circumstances in whic...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
Background Mortality in HIV-infected patients has declined substantially with combination antiretrov...
Background: Using data from a large European collaborative study, we aimed to identify the circumsta...
BACKGROUND: Using data from a large European collaborative study, we aimed to identify the circumst...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
Background: In resource-limited countries, estimating CD4-specific incidence rates of mortality and ...
Abstract Background The risk of HIV-1 related mortality is strongly related to CD4 count. Guidance o...
Using data from a large European collaborative study, we aimed to identify the circumstances in whic...
Background: Due to the success of antiretroviral therapy (ART), it is relevant to ask whether death ...
Using data from a large European collaborative study, we aimed to identify the circumstances in whic...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 ...
Summary Background Whether people living with HIV who have not received antiretroviral therapy (ART)...
BACKGROUND: Whether people living with HIV who have not received antiretroviral therapy (ART) and ha...
Background Mortality in HIV-infected patients has declined substantially with combination antiretrov...
Background: Using data from a large European collaborative study, we aimed to identify the circumsta...
BACKGROUND: Using data from a large European collaborative study, we aimed to identify the circumst...
Background: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretrovira...
(1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as we...
International audienceTo identify the risk factors associated with presentation for care with CD4 ce...
Background: In resource-limited countries, estimating CD4-specific incidence rates of mortality and ...
Abstract Background The risk of HIV-1 related mortality is strongly related to CD4 count. Guidance o...
Using data from a large European collaborative study, we aimed to identify the circumstances in whic...
Background: Due to the success of antiretroviral therapy (ART), it is relevant to ask whether death ...
Using data from a large European collaborative study, we aimed to identify the circumstances in whic...